6195-45-5

Basic information

• Product Name: meso-1,3,4,5,6-penta-O-benzyl-myo-inositol
• Synonyms: meso-1,3,4,5,6-penta-O-benzyl-myo-inositol
• CAS NO: 6195-45-5
• Molecular Weight: 630.781
• Mol File: 6195-45-5.mol
• Article Data: 36

Chemical Properties

• CAS DataBase Reference: meso-1,3,4,5,6-penta-O-benzyl-myo-inositol(CAS DataBase Reference)
• NIST Chemistry Reference: meso-1,3,4,5,6-penta-O-benzyl-myo-inositol(6195-45-5)
• EPA Substance Registry System: meso-1,3,4,5,6-penta-O-benzyl-myo-inositol(6195-45-5)

Safety Data

• Hazardous Substances Data: 6195-45-5(Hazardous Substances Data)

Upstream product

• 6195-73-9 1⁽³⁾-O-(2-tetrahydropyranyl)-2,3⁽¹⁾,4⁽⁶⁾,5,6⁽⁴⁾-penta-O-benzyl-sn-myoinositol 
• 132437-55-9 1-O-allyl-2,3,4,5,6-penta-O-benzyl-D-myo-inositol 
• 114218-29-0 (+/-)-1-O-allyl-2,3,4,5,6-pentakis-O-benzyl myo-inositol 
• 129261-63-8 (+)-1D-2,3,4,5-tetra-O-benzyl-1-O-(4-methoxybenzyl)-myo-inositol 
• 100-39-0 benzyl bromide 
• 111828-82-1 D-1-O-[(1S)-(-)-camphanoyl]-2,3,4,5,6-penta-O-benzyl-myo-inositol 
• 93238-43-8 1-O-(2,3,4,6-tetra-O-benzyl-α-D-mannopyranosyl)-2,3,4,5,6-penta-O-benzyl-sn-myo-inositol 
• 801297-69-8 1D-1-O-benzoyl-2,3,4,5,6-penta-O-benzyl-myo-inositol 
• 10583-42-3 (+/-)-1-O-allyl-3,4,5,6-tetrakis-O-benzyl myo-inositol 
• 26276-99-3 rac-1,4,5,6-tetra-O-benzyl-myo-inositol 
• 6195-45-5 DL-2,3,4,5,6-penta-O-benzyl-myo-inositol 
• 81927-55-1 O-benzyl 2,2,2-trichloroacetimidate 
• 498554-88-4 1D-4,5,6-tri-O-benzyl-3-deoxy-1-O-p-methoxybenzyl-myo-inositol 
• 800409-00-1 1D-2,3-anhydro-4,5,6-tri-O-benzyl-1-O-p-methoxybenzyl-myo-inositol 

Downstream Products

• 135080-35-2 2,3,4,5,6-penta-O-benzyl-1-deoxy-1-fluoro-scyllo-inositol 
• 137128-35-9 (+/-)-10H-phenothiazine-10-propanoyl-2',3',4',5',6'-penta-O-benzyl-1'-myo-inositol 
• 22144-57-6 meso-2,3,4,5,6-O-pentabenzyl-scyllo-ionose 
• 141820-81-7 DL-2,3,4,5,6-penta-O-benzyl-1-O-<(1,2-O-isopropylidene-sn-3-glyceryloxy)methyl>-myo-inositol 
• 143570-29-0 Thiophosphoric acid S-butyl ester O-((1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentakis-benzyloxy-cyclohexyl) ester 
• 143570-28-9 Thiophosphoric acid S-octyl ester O-((1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentakis-benzyloxy-cyclohexyl) ester 
• 143570-27-8 Thiophosphoric acid S-dodecyl ester O-((1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentakis-benzyloxy-cyclohexyl) ester 
• 143570-26-7 Thiophosphoric acid O-((1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentakis-benzyloxy-cyclohexyl) ester S-tetradecyl ester 
• 143570-25-6 Thiophosphoric acid S-hexadecyl ester O-((1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentakis-benzyloxy-cyclohexyl) ester 
• 144944-72-9 Thiophosphoric acid S-(2,3-bis-octyloxy-propyl) ester O-((1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentakis-benzyloxy-cyclohexyl) ester 
• 146491-05-6 Thiophosphoric acid S-(2-methoxy-3-octadecyloxy-propyl) ester O-((1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentakis-benzyloxy-cyclohexyl) ester 
• 143599-66-0 Decanoic acid 1-decanoyloxymethyl-2-[hydroxy-((1S,2S,3R,4S,5S,6S)-2,3,4,5,6-pentakis-benzyloxy-cyclohexyloxy)-phosphorylsulfanyl]-ethyl ester 
• 144944-53-6 Thiophosphoric acid S-(2,3-bis-octadecyloxy-propyl) ester O-((1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentakis-benzyloxy-cyclohexyl) ester 
• 143570-38-1 Hexadecanoic acid 1-hexadecanoyloxymethyl-2-[hydroxy-((1S,2S,3R,4S,5S,6S)-2,3,4,5,6-pentakis-benzyloxy-cyclohexyloxy)-phosphorylsulfanyl]-ethyl ester 

Relevant articles and documents

A novel, mild palladium mediated deprotection of O-allyl and prop-1-enyl ethers

A mild method for the deprotection of diverse O-allyl (1a-5a) and prop-1-enyl ethers (1d-5d) of glycosides and inositol by use of PdCl2/CuCl/DMF-H2O/O2 is described.

ACETYLATED PRODRUGS FOR DELIVERY ACROSS THE BLOOD-BRAIN BARRIER

The present disclosure relates to pharmaceutical compositions including a compound derived from a parent compound having a hydroxyl or amino moiety, wherein the hydroxyl in the parent compound is presented as an ester in the compound or the amino in the parent compound is presented as an amide in the compound, and their use to prevent or treat neurological disease.

The orientation of the β-hydroxyl group controls the diastereoselectivity during the hydride reduction and Grignard reaction of inososes

A comparison of the results of the Grignard reaction and the hydride reduction of the carbonyl group of epi- and scyllo-inososes reveals that the extent of diastereoselectivity of these reactions is decided by the orientation of the β-hydroxyl group (or i